Literature DB >> 8873548

Minimum alveolar concentration of halothane and enflurane are decreased in early pregnancy.

M T Chan1, P Mainland, T Gin.   

Abstract

BACKGROUND: Minimum alveolar concentration (MAC) of isoflurane is decreased in early pregnancy but it is not known whether this occurs to the same extent with other inhalational anesthetics. The MAC of halothane and enflurane were compared in pregnant women undergoing elective termination of pregnancy and in nonpregnant women.
METHODS: We studied 16 pregnant women scheduled for termination of pregnancy at 8 to 13 weeks gestation and 16 non-pregnant patients undergoing laparoscopic sterilization. Eight patients in each group received halothane and the others received enflurane. After inhalational induction of anesthesia and tracheal intubation, MAC was determined in each patient by observing the motor response to a 10-s, 50-Hz, 80-mA transcutaneous electric tetanic stimulus to the ulnar nerve at varying concentrations of either halothane or enflurane. The end-tidal concentration of inhalational anesthetic was kept constant for at least 15 min before each stimulus and the concentration was varied ultimately in steps of 0.05 vol% (halothane) or 0.10 vol% (enflurane) until a sequence of three alternate responses (move, not move, move) or (not move, move, not move) was obtained. Minimum alveolar concentration for each person was taken as the mean of the two concentrations just permitting and just preventing movement, and MAC for the group was the median of individual MAC values. Confidence intervals were calculated for the percentage decrease in MAC for pregnant women compared with nonpregnant women.
RESULTS: The median (range) MAC of halothane, 0.58 vol% (0.53 to 0.58), and enflurane, 1.15 vol% (0.95-1.25), in the pregnant women were less than those in the nonpregnant women, 0.75 vol% (0.70 to 0.78), P = 0.0005 and 1.65 vol% (1.45 to 1.75), P = 0.0007, respectively. The percentage decrease (95% CI) in MAC for pregnant women was 27% (20 to 27%) for halothane and 30% (24 to 36%) for enflurane.
CONCLUSIONS: The MAC of halothane and enflurane were reduced by a similar degree in pregnant women at 8 to 13 weeks gestation compared with nonpregnant women.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873548     DOI: 10.1097/00000542-199610000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications.

Authors:  Gideon Koren; Gali Pariente
Journal:  Pharm Res       Date:  2018-02-12       Impact factor: 4.200

Review 2.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 3.  An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics.

Authors:  Ahizechukwu C Eke
Journal:  J Basic Clin Physiol Pharmacol       Date:  2021-12-08

4.  Women have the same desflurane minimum alveolar concentration as men: a prospective study.

Authors:  Anupama Wadhwa; Jaleel Durrani; Papiya Sengupta; Anthony G Doufas; Daniel I Sessler
Journal:  Anesthesiology       Date:  2003-11       Impact factor: 7.892

5.  Clinical therapeutics in pregnancy.

Authors:  Maisa N Feghali; Donald R Mattison
Journal:  J Biomed Biotechnol       Date:  2011-07-06

Review 6.  Physiological and anatomical changes of pregnancy: Implications for anaesthesia.

Authors:  Pradeep Bhatia; Swati Chhabra
Journal:  Indian J Anaesth       Date:  2018-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.